Literature DB >> 10956310

Secondary prevention: improving outcomes following myocardial infarction.

A P Maggioni1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956310      PMCID: PMC1766529          DOI: 10.1136/heart.84.suppl_1.i5

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  4 in total

1.  Cost-effectiveness analysis of early lisinopril use in patients with acute myocardial infarction. Results from GISSI-3 trial.

Authors:  M G Franzosi; A P Maggioni; E Santoro; G Tognoni; E Cavalieri
Journal:  Pharmacoeconomics       Date:  1998-03       Impact factor: 4.981

2.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Authors:  L Køber; C Torp-Pedersen; J E Carlsen; H Bagger; P Eliasen; K Lyngborg; J Videbaek; D S Cole; L Auclert; N C Pauly
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245

3.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

4.  Epidemiology of post-infarction risk stratification strategies in a country with a low volume of revascularization procedures. GISSI-Prognosis Investigators.

Authors:  A P Maggioni; L Tavazzi; G Fabbri; D Lucci; E Santoro; A Canonico; M Galli; F Achilli; G Tognoni
Journal:  Eur Heart J       Date:  1998-12       Impact factor: 29.983

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.